Tumor Necrosis Factor Alpha (Tnf Α) Biomarker is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Property |
Value |
| Category |
Inflammatory Cytokine |
| Target |
TNF-α |
| Sample Type |
CSF, Blood, Serum |
| Diseases |
AD, PD, ALS, HD, MS, Stroke |
| Role |
Pro-inflammatory cytokine, cell death |
Tumor necrosis factor alpha (TNF-α) is a potent pro-inflammatory cytokine produced by activated microglia, astrocytes, macrophages, and neurons. It plays a central role in the innate immune response and has been strongly implicated in the pathogenesis of neurodegenerative diseases through its effects on neuroinflammation, synaptic function, and neuronal survival.
¶ Structure and Function
TNF-α is synthesized as a 26 kDa transmembrane precursor that is cleaved by TACE (TNF-α converting enzyme, also known as ADAM17) to release the soluble 17 kDa trimeric form. The soluble TNF-α binds to two distinct receptors: TNFR1 (p55) which mediates pro-inflammatory and pro-apoptotic signaling, and TNFR2 (p75) which primarily mediates protective and regenerative responses.
- Pro-inflammatory signaling: Activates NF-κB and MAPK pathways
- Apoptosis induction: Through TNFR1 caspase-8 activation
- Glial activation: Potent activator of microglia and astrocytes
- Synaptic dysfunction: Reduces synaptic plasticity and function
- Blood-brain barrier: Increases permeability
- Elevated CSF and blood TNF-α in AD patients
- Correlates with cognitive decline and brain atrophy
- Associated with amyloid and tau pathology
- Predicts conversion from MCI to AD
- Increased CSF and serum TNF-α in PD
- Associated with motor symptom severity
- Linked to dopaminergic neuron degeneration
- May predict disease progression
- Elevated in CSF and serum of ALS patients
- Correlates with disease progression
- Associated with microglial activation
- Potential marker for therapeutic response
- Elevated in CSF during acute relapses
- Associated with lesion activity
- Monitors disease-modifying therapy response
| Method |
Sensitivity |
Clinical Use |
| ELISA |
pg/mL |
Research, clinical |
| Simoa |
fg/mL |
Ultra-sensitive detection |
| Meso Scale Discovery |
High |
Multiplex panels |
| Luminex |
High |
Cytokine panels |
| Flow cytometry |
Intracellular |
Cell-specific |
Targeting TNF-α:
- Etanercept: TNF receptor-Fc fusion, tested in AD/PD
- Infliximab: Anti-TNF antibody, neuroinflammation trials
- Adalimumab: Anti-TNF antibody
- Minocycline: Indirect TNF-α inhibition, ALS trials
| Disease |
CSF Level |
Blood Level |
Prognostic Value |
| AD |
↑ Elevated |
↑ Elevated |
High |
| PD |
↑ Elevated |
↑ Elevated |
Moderate |
| ALS |
↑ Elevated |
↑ Elevated |
High |
| HD |
↑ Elevated |
↑ Elevated |
Moderate |
| MS |
↑ In relapse |
Variable |
High |
The study of Tumor Necrosis Factor Alpha (Tnf Α) Biomarker has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- McCoy MK, Tansey MG. TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflammation. 2008;5:45. PMID:18925963
- Perry RT, Collins JS, Wiener H, et al. The role of TNF and its receptors in Alzheimer's disease. Neurobiol Aging. 2001;22(6):873-883. PMID:11754994
- Swardfager W, Lanctôt K, Rothenburg L, et al. A meta-analysis of cytokines in Alzheimer's disease. Biol Psychiatry. 2010;68(10):930-941. PMID:20692646
- Nagatsu T, Sawada M. Inflammatory cytokines in Parkinson's disease. J Neural Transm Suppl. 2006;(71):53-56. PMID:17417955
- Tweedie D, Sambamurti K, Greig NH. TNF-alpha inhibitor as a potential therapeutic approach for Alzheimer's disease. Open Drug Discov J. 2010;2:8-17. PMID:21857857
- Kummer MP, Heneka MT. Truncated and modified amyloid-β species. Cold Spring Harb Perspect Med. 2014;4(11):a006148. PMID:24892650
- Wang WY, Tan MS, Yu JT, Zhang L. Role of pro-inflammatory cytokines in the pathophysiology of Alzheimer's disease. J Alzheimers Dis. 2015;47(2):305-314. PMID:26472226
- Frankola KA, Grewal NK, Haapalinna A, et al. Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases. CNS Neurol Disord Drug Targets. 2011;10(3):391-403. PMID:21288185